TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SNAPLVV

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SNAPLVV

ST13

US500000098313178

Classe

40, 42

Pedido

98313178

Registro

8146203

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

29

Atualização mais recente

17/02/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

40, 42

Data de depósito

13/12/2023

Data de registro

17/02/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

17/02/2026

Última transação

17/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

2024-02-00

Primeiro uso no comércio

2024-02-00

Código do desenho

4

Tipo de titular

03

Localização do titular

San Diego, CA, US

Examinador

STAHL, NICHOLE MARIE

Unidade examinadora

L70

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

National Resilience, Inc.

Representantes

Susan M. Natland Baker & Hostetler LLP

Classificação técnica

Classes Nice

Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 40

Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology

Classe 42

Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services in the field of biological treatment and bioproduction; design and development of biotechnology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, provision of information for research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services, namely, the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins

Publicações

Histórico de despachos e eventos da marca no USPTO.

29 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

17/02/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

17/02/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/02/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/02/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/02/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/02/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/02/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/02/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

11/02/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

26/01/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

26/01/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

14/10/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

14/10/2025

IUAF

USE AMENDMENT FILED

12/05/2025

EISU

TEAS STATEMENT OF USE RECEIVED

12/05/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

26/11/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/10/2024

PUBO

PUBLISHED FOR OPPOSITION

15/10/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/09/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/08/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

30/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/07/2024

GNRT

NON-FINAL ACTION E-MAILED

16/07/2024

CNRT

NON-FINAL ACTION WRITTEN

16/07/2024

DOCK

ASSIGNED TO EXAMINER

12/07/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

18/03/2024

NWAP

NEW APPLICATION ENTERED

13/12/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SNAPLVV ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.